Skip to Content

WPI 3293 (Telmisartan 40 mg)

Pill with imprint WPI 3293 is White, Capsule-shape and has been identified as Telmisartan 40 mg. It is supplied by Watson Laboratories, Inc..

Telmisartan is used in the treatment of high blood pressure; cardiovascular risk reduction; prevention of cardiovascular disease and belongs to the drug class angiotensin receptor blockers. There is positive evidence of human fetal risk during pregnancy. Telmisartan 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3293

Telmisartan 40 mg WPI 3293 Front
Telmisartan 40 mg WPI 3293 Back

Telmisartan

Imprint
WPI 3293
Strength
40 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Angiotensin receptor blockers
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-3293

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.